These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24289627)

  • 1. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
    Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
    J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
    Fan NJ; Gao CF; Zhao G; Wang XL; Liu QY
    Diagn Pathol; 2012 Apr; 7():45. PubMed ID: 22521044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of nephrotic syndrome in serum using magnetic bead based sample fractionation & MALDI-TOF MS.
    Sui W; Dai Y; Zhang Y; Chen J; Liu H; Huang H
    Indian J Med Res; 2012 Mar; 135(3):305-11. PubMed ID: 22561615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C; Pan C; Shen J; Wang H; Yong L
    Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
    Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF
    Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
    Ying X; Han SX; Wang JL; Zhou X; Jin GH; Jin L; Wang H; Wu L; Zhang J; Zhu Q
    Diagn Pathol; 2013 Aug; 8():130. PubMed ID: 23915185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum proteomic profiling for the early diagnosis of colorectal cancer.
    Zhu D; Wang J; Ren L; Li Y; Xu B; Wei Y; Zhong Y; Yu X; Zhai S; Xu J; Qin X
    J Cell Biochem; 2013 Feb; 114(2):448-55. PubMed ID: 22961748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.
    Liao CC; Mehta A; Ward NJ; Marsh S; Arulampalam T; Norton JD
    World J Surg Oncol; 2010 Apr; 8():33. PubMed ID: 20420661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
    Li K; He WH; Fan NJ; Gao CF; Zhao G; Sun GB; Zheng GB
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():147-52. PubMed ID: 25910294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
    Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
    Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
    Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.